BusinessMedical Devices

Global Q-PCR and D-PCR Devices Market Set to Grow at Healthy CAGR of 9.1 % by 2026 with top Key players like Bio-Rad Laboratories, QIAGEN, Takara Bio, Agilent Technologies

Global Q-PCR and D-PCR Devices Market

Q-PCR and D-PCR devices are instruments for quantification and amplification of nucleic acids which includes DNA, cDNA, methylated DNA, or RNA. Q-PCR and D-PCR are quantitative, Digital PCR is a next-generation testing method which helps precise quantification of nucleic acids. qPCR is still the best choice and remains the “gold-standard” method for nucleic acid target quantification. If a larger dynamic range, cost or monitoring real-time reaction efficiency are considerations for your application, then qPCR is preferable to dPCR.

The Q-PCR and D-PCR Devices Market accounted to USD 4.5 billion growing at a CAGR of 9.1% during the forecast to 2026.

Key Market Competitors: Global Q-PCR and D-PCR Devices Market

Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., QIAGEN, Takara Bio, Inc., Agilent Technologies, Inc., Biomérieux S.A., Fluidigm Corporation, Danaher, Abbott, Merck KGaA, BD, Promega Corporation, Meridian Bioscience, Inc., Analytik Jena AG, BioFire Diagnostics,Hoffman-La Roche Ltd., Cepheid, among others

Get a FREE Sample Copy of the Report @

The Q-PCR and D-PCR Devices Market report includes a discussion of the key market trends of past and present time affecting client’s requirements and having a significant influence on the overall development of the market’s growth. A detailed analysis of the key drivers and restraints are also included in the report. Along with an analytical overview of the prospect impact of these factors on the future growth prospects of the market. The report Displays the Competitive nature among key manufacturers, with market share, revenue and sales

Market Restraint

  • High initial costs for installing the equipment’s
  • Lack of knowledge and skilled professionals

Market Drivers

  • Increasing prevalence of infectious diseases and genetic disorders
  • R&D investments by pharmaceutical companies
  • Technological advancement to adopt the new technology
  • Increase in usage of biomarkers for diagnosis of diseases

Table of Contents:

Part 01: Executive Summary

Part 02: Scope of The Report

Part 03: Global Q-PCR and D-PCR Devices Market Landscape

Part 04: Global Q-PCR and D-PCR Devices Market Sizing

Part 05: Global Q-PCR and D-PCR Devices Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis


  • By Technology
    • Quantitative PCR
    • Digital PCR
  • By Product Type
    • Reagents
    • Consumables
    • Instruments
    • Software
  • By Application
    • Clinical applications
      • Pathogen testing
      • Oncology testing
      • Blood screening
      • Others
    • Research
    • Forensic
    • Others
  • By End User
    • Hospitals
    • Diagnostic centers
    • Research laboratories
    • Academic institutes
    • Pharmaceutical
    • Biotechnology companies
    • Clinical research organizations
    • Forensic laboratories
  • By Geography
    • North America
      • US
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
      • Turkey
      • Belgium
      • Netherlands
      • Switzerland
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • South Korea
      • India
      • Australia
      • Singapore
      • Thailand
      • Malaysia
      • Indonesia
      • Philippines
      • Rest of Asia Pacific
    • Middle East & Africa
      • South Africa
      • Egypt
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Rest of Middle East & Africa

Competitive Analysis: 

Global Q-PCR and D-PCR devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. The report includes market shares of Q-PCR and D-PCR devices market for Global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

 Key Developments in the Market:

  • In July 2017, Agilent Technologies Inc. expanded its portfolio of instruments for molecular diagnostics as their introduction of the AriaDx Real-Time PCR System. AriaDx is the only modular real-time PCR instrument in the market intended for in vitro diagnostic use, new AriaDx Real-Time PCR System has been designed and manufactured to according to standards and is CE marked for use in in vitro diagnostics.
  • In October 2012, Life Tech Remains Leader of qPCR Research Market customer spending on qPCR reagents is expected to spike over years, espondents cited flexibility, data quality, well‐to‐well consistency, and available applications as the main criteria in purchasing a new instrument.

10% Extra Discount for Early Buyer, Know More @

Reasons to Purchase this Report

  • Current and future of global Q-PCR and D-PCR devices market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *